Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 629,700 shares, a growth of 116.0% from the March 31st total of 291,500 shares. Based on an average daily trading volume, of 985,800 shares, the days-to-cover ratio is presently 0.6 days. Approximately 1.7% of the shares of the stock are sold short.
Analysts Set New Price Targets
ALUR has been the subject of several recent research reports. Chardan Capital initiated coverage on shares of Allurion Technologies in a research report on Thursday, April 4th. They issued a “buy” rating and a $5.00 price target for the company. Jefferies Financial Group started coverage on shares of Allurion Technologies in a research report on Friday, February 9th. They issued a “buy” rating and a $5.00 price target for the company.
Get Our Latest Report on Allurion Technologies
Allurion Technologies Stock Up 3.8 %
Allurion Technologies (NYSE:ALUR – Get Free Report) last issued its quarterly earnings data on Thursday, March 21st. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.51) by ($0.12). The firm had revenue of $8.24 million for the quarter, compared to analysts’ expectations of $8.20 million. As a group, sell-side analysts forecast that Allurion Technologies will post -0.87 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the company. Accredited Investors Inc. bought a new stake in Allurion Technologies in the third quarter worth about $161,000. Alpine Global Management LLC bought a new stake in Allurion Technologies in the third quarter worth about $97,000. Finally, RTW Investments LP bought a new stake in Allurion Technologies in the third quarter worth about $14,868,000. 21.39% of the stock is owned by institutional investors.
Allurion Technologies Company Profile
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Read More
- Five stocks we like better than Allurion Technologies
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MarketBeat Week in Review – 4/22 – 4/26
- What Does Downgrade Mean in Investing?
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the Hang Seng index?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.